This week, the Brazilian health research institute involved in the country’s top COVID-19 vaccine, CoronaVac, announced that the drug is actually much less effective than previously reported. Still, many health officials insist it’s a good vaccine. This comes amid an already chaotic government response to the pandemic and rising numbers of deaths as Brazil suffers from its second wave. Michael Fox has the story.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?